Dynamic profile of the HBeAg-anti-HBe system in acute and chronic hepatitis B virus infection: A clinical-laboratory approach
- PMID: 33296069
- DOI: 10.1007/s11033-020-06056-4
Dynamic profile of the HBeAg-anti-HBe system in acute and chronic hepatitis B virus infection: A clinical-laboratory approach
Abstract
Wild-type HBV infection is followed by the blood expression of its widely known serological markers of infection, and designated as, hepatitis B virus surface antigen (HBsAg) and its antibody (anti-HBs), anti-HBc antibodies (IgM/IgG), and hepatitis B virus 'e' antigen (HBeAg) and its antibody (anti-HBe). These markers are detected as the infection develops and its kinetic behavior serves as a basis for monitoring the disorder and for diagnosing the clinical form or infection phase. Among these, the HBeAg-anti-HBe system markers demonstrate a dynamic profile whose interpretation, both in the acute or chronic HBV infection context, can offer greater difficulty to the health professionals, due to its particularities. This review offers a revisit to the markers dynamics of this system in the acute and chronic HBV infection and to the clinical and laboratory significance of its expression in these two clinical contexts.
Keywords: Acute HBV infection; Anti-HBe antibodies; Chronic HBV infection; HBe Antigen; Hepatitis B virus.
Similar articles
-
Detection of hepatitis B virus surface antigen, IgM and IgG antibodies to hepatitis B virus core antigen in the clinical classification and epidemiological surveillance of HBV infection.Mol Biol Rep. 2025 Feb 4;52(1):195. doi: 10.1007/s11033-025-10278-9. Mol Biol Rep. 2025. PMID: 39903324 Review.
-
A large-scale analysis study on the clinical and viral characteristics of hepatitis B infection with concurrence of hepatitis B surface or E antigens and their corresponding antibodies.Genet Mol Res. 2017 Feb 23;16(1). doi: 10.4238/gmr16019102. Genet Mol Res. 2017. PMID: 28252163
-
[Atypical serological profiles in hepatitis B infections: investigation of S gene mutations in cases with concurrently positive for HBsAg and anti-HBs].Mikrobiyol Bul. 2016 Oct;50(4):535-543. doi: 10.5578/mb.32197. Mikrobiyol Bul. 2016. PMID: 28124958 Turkish.
-
Clinical, biochemical, immunological and virological profiles of, and differential diagnosis between, patients with acute hepatitis B and chronic hepatitis B with acute flare.J Gastroenterol Hepatol. 2008 Nov;23(11):1728-33. doi: 10.1111/j.1440-1746.2008.05600.x. Epub 2008 Sep 24. J Gastroenterol Hepatol. 2008. PMID: 18823435
-
Detection of the serological markers hepatitis B virus surface antigen (HBsAg) and hepatitis B core IgM antibody (anti-HBcIgM) in the diagnosis of acute hepatitis B virus infection after recent exposure.Microbiol Immunol. 2022 Jan;66(1):1-9. doi: 10.1111/1348-0421.12943. Epub 2021 Oct 25. Microbiol Immunol. 2022. PMID: 34528725 Review.
Cited by
-
Novel Biomarkers of Hepatitis B Virus and Their Use in Chronic Hepatitis B Patient Management.Viruses. 2021 May 21;13(6):951. doi: 10.3390/v13060951. Viruses. 2021. PMID: 34064049 Free PMC article. Review.
-
High-sensitivity HBV DNA test for the diagnosis of occult HBV infection: commonly used but not reliable.Front Cell Infect Microbiol. 2023 May 16;13:1186877. doi: 10.3389/fcimb.2023.1186877. eCollection 2023. Front Cell Infect Microbiol. 2023. PMID: 37260698 Free PMC article. Review.
-
Detection of hepatitis B virus surface antigen, IgM and IgG antibodies to hepatitis B virus core antigen in the clinical classification and epidemiological surveillance of HBV infection.Mol Biol Rep. 2025 Feb 4;52(1):195. doi: 10.1007/s11033-025-10278-9. Mol Biol Rep. 2025. PMID: 39903324 Review.
-
Influence of Occult Hepatitis B Infection on Blood Transfusion Safety and Its Countermeasures.Pathogens. 2025 Mar 21;14(4):301. doi: 10.3390/pathogens14040301. Pathogens. 2025. PMID: 40333041 Free PMC article. Review.
-
Application Effect and Accuracy Analysis of Electrochemiluminescence Immunoassay and Enzyme-Linked Immunosorbent Assay in the Serological Test of Hepatitis B Virus.Evid Based Complement Alternat Med. 2022 Aug 4;2022:9371497. doi: 10.1155/2022/9371497. eCollection 2022. Evid Based Complement Alternat Med. 2022. Retraction in: Evid Based Complement Alternat Med. 2023 Jun 21;2023:9861567. doi: 10.1155/2023/9861567. PMID: 35966724 Free PMC article. Retracted.
References
-
- World Health Organization (2017) Global Hepatitis Report (2017) WHO, Geneva. https://apps.who.int/iris/bitstream/handle/10665 /25501 6/97892 41565 455-eng.pdf;jsessionid=E755A 57371 4A211 D864D 6FECC 4B18D 47?sequence=1
-
- Schillie S, Vellozzi C, Reingold A, Harris A, Haber P, Ward JW, Nelson NP (2018) Prevention of hepatitis B virus infection in the United States: recommendations of the advisory committee on immunization practices. MMWR Recomm Rep 67(1):1–31. https://doi.org/10.15585/mmwr.rr6701a1 - DOI - PubMed - PMC
-
- Kidd-Ljunggren K, Holmberg A, Bläckberg J, Lindqvist B (2006) High levels of hepatitis B virus DNA in body fluids from chronic carriers. J Hosp Infect 64(4):352–357 - PubMed
-
- Shih YF, Liu CJ (2017) Mother-to-infant transmission of hepatitis B virus: challenges and perspectives. Hepatol Int 11(6):481–484 - PubMed
-
- Ali BA, Huang TH, Salem HH, Xie QD (2006) Expression of hepatitis B virus genes in early embryonic cells originated from hamster ova and human spermatozoa transfected with the complete viral genome. Asian J Androl 8:273–279 - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources